AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo
If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.
If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.
The International Society of Aesthetic Plastic Surgery has elected plastic surgeon Ozan Sozer, MD, as president-elect, with his term as president set to begin in 2028.